Of the candidate genes thought to be logical for an individual's hypertension susceptibility, endothelial nitric oxide (NO) synthase gene (protein: eNOS and gene: eNOS) ranks high. Evidence is mounting suggesting that enhanced production or bioavailability of the enzyme eNOS that synthesizes NO in endothelial cells may lead to the constitutive release of NO, which exerts vasoprotective effects in blood pressure (BP) regulation.
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The eNOS spans 21 kb with 26 exons on chromosome 7q35-36. The candidacy for eNOS in the development of hypertension has a strong biological basis. Knockout mice deficient in eNOS had hypertension as adults. 2 In contrast, induction of eNOS cDNA in mice reduced BP. 3 As the genomic sequence of eNOS is highly polymorphic, it is of added interest to these findings to confirm which variant(s) at eNOS might have a functional potential to affect the final bioavailability of eNOS, and thus the development of hypertension. Genetic association studies regarding the relationship between eNOS variants and hypertension, however, have yielded inconsistent results. [4] [5] [6] Apparent inconsistency generally reflects a lack of statistical power because of a small sample size. To address this issue, we focused on a large Han Chinese population to explore the possible association of the three most widely studied eNOS variants (TÀ786C, 4a/b and G894T), both individually and as haplotypes, with essential hypertension.
All studied subjects are Fangshan Han Chinese enrolled in a population-based study design as described elsewhere. 7 We recruited 1305 unrelated hypertensive subjects (male/female: 712/593) agedo60 years with systolic BPX140 mm Hg or diastolic BPX90 mm Hg, and they were free of secondary forms of hypertension through extensive laboratory and clinical examination and without any antihypertensive treatment. Also, we collected 1154 normotensive subjects (males/females: 469/685) with systolic BP/diastolic BP below 140/90 mm Hg and without familial hypertension history. BP measurements were obtained by experienced examiners according to a standard protocol recommended by the American Heart Association. 8 This study was approved by the Ethics Committee of Peking Union Medical College and written informed consent was obtained from each subject. Genomic DNA was extracted from leukocytes and genotyping was detected by PCR with restriction analysis when appropriate. Amplification of G894T was performed using primers 5 0 -TCCCTGAGGAGG GCATGAGGCT-3 0 (sense) and 5 0 -TGAGGGTCGCA CAGGTTCCT-3 0 (antisense). Restriction enzyme MboI recognized the amplified fragment (206-bp) when 894T was present (119-bp and 87-bp). TÀ786C and 4a/b variants were genotyped according to an earlier report. 1 Laboratory genotyping was performed by Niu and Qi blinded to case-control status. To avoid genotyping misclassification, a known marker was added for each PCR or digested product. Also each genotype was confirmed by DNA sequencing (BGI LifeTech Co., Ltd., Beijing, China).
Statistical analyses were performed using SAS 9.1.3 version (Institute Inc., Cary, NC, USA). HardyWeinberg equilibrium and differences of genotype/ allele distributions were calculated by w 2 -test. Each genotype was assessed by logistic regression analysis assuming additive (major homozygotes versus heterozygotes versus minor homozygotes), dominant (major homozygotes versus heterozygotes plus minor homozygotes) and recessive (major homozygotes plus heterozygotes versus minor homozygotes) modes of inheritance, respectively. Two-tailed Po0.05 was accepted as statistically significant.
EH/EH þ program, a likelihood method for depicting allele associations, was employed to estimate haplotype frequencies, which were compared between case-control groups by w 2 -test from a series of 2 Â 2 contingency tables by combining other haplotypes. Bonferroni-corrected Po0.00625 (0.05/8) was considered significant.
There were no deviations from Hardy-Weinberg equilibrium except for G894T in hypertensive group (Po0.05). Significant differences were observed in the genotype and allele distributions of TÀ786C and 4a/b, and in G894T genotype distribution (Table 1) . For each variant, results from logistic regression analysis showed significant associations of TÀ786C (odds ratio (OR) dominant ¼ 1.52; 95% confidence interval (CI): 1.22-1.88; P ¼ 0.0002), 4a/b (OR dominant ¼ 1.29; 95% CI: 1.06-1.58; P ¼ 0.0110) and G894T (OR recessive ¼ 2.10; 95% CI: 1.20-3.67; P ¼ 0.0092) with the increased risk of essential hypertension. No significant differences were observed in age, body mass index, BP and plasma lipid levels across genotypes of all studied variants (see online materials Supplementary Table 2) .
Of the eight different combinations of haplotypes for the three variants tested, haplotypes H 1 (OR ¼ 2.90; 95% CI: 2.10-4.01; Po0.0001) and H 2 (OR ¼ 11.12; 95% CI: 3.31-69.16; P ¼ 0.0011) had an increased risk for essential hypertension, whereas haplotypes H 3 (OR ¼ 0.58; 95% CI: 0.42-0.80; P ¼ 0.0008) and H 5 (OR ¼ 0.69; 95% CI: 0.53-0.89; P ¼ 0.0053) had a reduced risk even after Bonferroni correction.
China is a united multi-nationality country with the biggest population in the world. To enhance study power and reduce genetic heterogeneity, we focused on a relatively homogeneous Han population. 8 It has been proposed that to generate robust data, a much larger sample involving 41000 subjects in each subgroup might be required; 9 our sample sizes confirmed our capacity to do this. This population-based case-control study, to our knowledge, was the largest so far to explore the association of the three most widely studied variants of eNOS, or combinations thereof, with essential hypertension.
We observed significant disequilibrium of G894T in hypertensive group. Genotyping error is an unlikely explanation because of the blinded genotype assessment and stringent genotyping protocol applied. As stated by Wigginton et al., 10 deviations from Hardy-Weinberg equilibrium, especially in affected individuals, can provide evidence for an association between the marker and disease susceptibility. Thus, this is yet an indication that G894T might be a genetic marker for essential hypertension.
Although no linkage support was obtained for eNOS, 11 two recent meta-analyses have revealed positive association between eNOS variants and hypertension. 5, 6 One meta-analysis conducted by Zintzaras et al. 5 demonstrated positive association between 4a/b variant and hypertension under a recessive mode, with 4b allele conferring a 22% reduced risk of hypertension in the overall population and a 24% reduced risk in Caucasians. Another OR; 95% CI; P-values were calculated using logistic regression analysis with (A) denoting additive mode, which was calculated as major homozygotes versus heterozygotes versus minor homozygotes, with (D) denoting dominant mode, which was calculated as major homozygotes versus heterozygotes plus minor homozygotes and with (R) denoting recessive mode, which was calculated as major homozygotes plus heterozygotes versus minor homozygotes. y OR; 95% CI; P-values were calculated using logistic regression analysis using the most common haplotype H 7 as a reference. z Ln (L) denoted likelihood ratio statistic for omnibus test in EH/EH+ program. meta-analysis by Pereira et al. 6 detected that carriers of 4a allele were associated with a 28% increase in the risk of hypertension compared with these homozygous for 4b allele. In this study, we found that the 4a allele carriers conferred a 29% increased risk of having hypertension (P ¼ 0.0110) compared with their 4b/4b counterparts, which was consistent with the results of Pereira et al. 6 Although we found that 4b allele was associated with a 27% reduced risk of hypertension under a recessive mode, which was similar to the reports of Zintzaras et al.,
5 no significant association of this variant with essential hypertension was observed in this study. This discrepancy may be because of the low frequency of 4a homozygotes.
As analysis of single variants can be misleading, persuasive evidence suggests a more prominent role of haplotypes when examining the role of eNOS variation in hypertension. 7 Earlier, Wang et al.
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investigated the effect of different eNOS variants on transcription activity and found that the À786C-4b combination had the highest transcriptional activity. A recent study evaluating the haplotype-based risk of hypertension demonstrated that the haplotype À786C-4b-894G was linked to a protective effect on hypertension risk. 4 Our haplotype results confirmed these findings in Chinese population and supported the potential interaction between TÀ786C and 4a/b variants. Two possible inferences can be drawn here. One is that the action of À786C-4a combination in haplotypes H 1 and H 2 had an important function with a risk-conferring effect on essential hypertension. Another inference is the gene synergistic action because the risk-reducing haplotypes H 3 (À786C-4b-894G) and H 5 (À786T-4a-894G) possessed the alternative allele at the first two sites; otherwise, the consistent role of the two haplotypes cannot be reached. Although statistical significance was observed both individually and in combination, the difference in BP levels across genotypes of these three variants remains nonsignificant. It opens the possibility that the studied variants, the overall contribution of which is minimal-and perhaps undetectable-but when considered in the context of the other gene(s) is non-negligible. Thus welldesigned studies with large numbers of variants and in a prospective design are needed to elucidate the specific role of these variants in disease pathogenesis.
Considering the sample size, the interaction of TÀ786C and 4a/b variants may have an important function in the pathogenesis of essential hypertension in the Han Chinese population. Whether this interaction affects the production or bioavailability of eNOS remains an open question, which reinforces the need to evaluate the functional consequences of these variants. What is known about this topic K Animal model studies have elucidated the important role of eNOS in the development of hypertension.
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K Genetic association studies regarding the relationship between eNOS variants and hypertension have yielded inconsistent results.
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K Although no linkage support was obtained for eNOS, 11 two recent meta-analyses have revealed positive association between eNOS variants and hypertension. 5, 6 What this study adds K We found significant associations in the genotype and allele distributions of TÀ786C and 4a/b, and in the G894T genotype distribution. K Under the three genetic modes of inheritance, we observed significant associations of TÀ786C (dominant), 4a/b (dominant) and G894T (recessive) with increased risk of essential hypertension. K In this population, our haplotype results supported the potential interaction between TÀ786C and 4a/b variants in the pathogenesis of essential hypertension.
